The evidence discussed in this article highlights the need for new therapeutic strategies that focus on alterations in the communication between different neural populations in the ARC and the GnRH neurons, taking into account the PCOS phenotype of each patient. Here, GNRH1 is linked to polycystic ovary syndrome.